Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy T Batchelor

Showing results (21-30 of 268) with videos related to

Pageof 27
Sort By:
Cancer|September 27, 2017
Diagnosis and management of primary central nervous system lymphomaCatherine H Han, Tracy T Batchelor
Neurosurgical Focus|December 1, 2006
Primary central nervous system lymphoma: presentation, diagnosis and stagingApril F Eichler, Tracy T Batchelor
Hematology/Oncology Clinics of North America|July 17, 2012
Primary central nervous system lymphoma: overview of current treatment strategiesPriscilla K Brastianos, Tracy T Batchelor
The New England Journal of Medicine|April 5, 2023
Understanding the Genetic Risk of <i>IDH</i>-Mutant GliomaTracy T Batchelor, Kyle M Walsh
Current Treatment Options in Oncology|October 24, 2002
Primary nervous system lymphomaScott R Plotkin, Tracy T Batchelor
Chinese Clinical Oncology|July 15, 2017
Isocitrate dehydrogenase mutation as a therapeutic target in gliomasCatherine H Han, Tracy T Batchelor
Expert Opinion on Investigational Drugs|August 13, 2009
Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastomaJörg Dietrich, Daphne Wang, Tracy T Batchelor
Continuum (Minneapolis, Minn.)|April 4, 2015
Primary CNS lymphoma and neurologic complications of hematologic malignanciesLakshmi Nayak, Elena Pentsova, Tracy T Batchelor
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 14, 2017
New Directions in Anti-Angiogenic Therapy for GlioblastomaNancy Wang, Rakesh K Jain, Tracy T Batchelor
Hematology. American Society of Hematology. Education Program|December 4, 2016
Management of primary central nervous system lymphoma in childrenLisa Giulino-Roth, Oussama Abla, Tracy T Batchelor
Pageof 27

Showing results (21-30 of 268) with videos related to

Sort By:
Pageof 27
Cancer|September 27, 2017
Diagnosis and management of primary central nervous system lymphomaCatherine H Han, Tracy T Batchelor
Neurosurgical Focus|December 1, 2006
Primary central nervous system lymphoma: presentation, diagnosis and stagingApril F Eichler, Tracy T Batchelor
Hematology/Oncology Clinics of North America|July 17, 2012
Primary central nervous system lymphoma: overview of current treatment strategiesPriscilla K Brastianos, Tracy T Batchelor
The New England Journal of Medicine|April 5, 2023
Understanding the Genetic Risk of <i>IDH</i>-Mutant GliomaTracy T Batchelor, Kyle M Walsh
Current Treatment Options in Oncology|October 24, 2002
Primary nervous system lymphomaScott R Plotkin, Tracy T Batchelor
Chinese Clinical Oncology|July 15, 2017
Isocitrate dehydrogenase mutation as a therapeutic target in gliomasCatherine H Han, Tracy T Batchelor
Expert Opinion on Investigational Drugs|August 13, 2009
Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastomaJörg Dietrich, Daphne Wang, Tracy T Batchelor
Continuum (Minneapolis, Minn.)|April 4, 2015
Primary CNS lymphoma and neurologic complications of hematologic malignanciesLakshmi Nayak, Elena Pentsova, Tracy T Batchelor
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 14, 2017
New Directions in Anti-Angiogenic Therapy for GlioblastomaNancy Wang, Rakesh K Jain, Tracy T Batchelor
Hematology. American Society of Hematology. Education Program|December 4, 2016
Management of primary central nervous system lymphoma in childrenLisa Giulino-Roth, Oussama Abla, Tracy T Batchelor
Pageof 27